Article

Correction of hypertriglyceridemia by intestinal microbiota remodeling alleviates NASH and atherosclerosis in severe combined hyperlipidemia disease

2022-12-21

Abstract excerpt

<h4>Background: </h4> Combined hyperlipidemia (CHL), characterized by elevated cholesterol and triglyceride levels in circulation, is a common risk factor of cardiovascular disease (CVD) accompanied by obesity, insulin resistance and fatty liver. Emerging lines of evidence demonstrate that intestinal microbiota plays a central role in the development of metabolic disease and the application of antibiotics can infl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c5fb8c19-8d69-5d74-96d7-806a60470791
DOI: 10.21203/rs.3.rs-2382598/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Correction of hypertriglyceridemia by intestinal microbiota remodeling alleviates NASH and atherosclerosis in severe combined hyperlipidemia diseaseDOI 10.21203/rs.3.rs-2382598/v1Read

Molecular characterization of gut microbiota in high‑lipid diet‑induced hyperlipidemic rats treated with simvastatinSemantic proximity Read

The gut microbiota promotes liver regeneration through hepatic membrane phospholipid synthesisSemantic proximity Read

HDL-C as a potential medium between depletion of <i>Lachnospiraceae</i> genera and hypertension under high-calorie dietSemantic proximity Read

The intestinal microbiota regulates host cholesterol homeostasisSemantic proximity Read

Establishment of animal models for NASH and utilization for mining associated gut microbiotaSemantic proximity Read

Alterations of ileal mucosa-associated microbiota in hypercholesterolemia patientsSemantic proximity Read

Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteriaSemantic proximity Read

Gut microbiota: a novel strategy affecting atherosclerosisSemantic proximity Read

Hydroxysafflor yellow A ameliorates high-fat diet-induced hyperlipidemia by attenuating hepatic lipotoxicity and partially restoring the gut microbiota–intestinal barrier axisSemantic proximity Read

Modulation of the Gut Microbiome by Novel Synthetic Glycans for the Production of Propionate and the Reduction of Cardiometabolic Risk FactorsSemantic proximity Read

Multi-omics analysis reveals gut microbiota remodeling and lipid metabolism regulation during the treatment of nonalcoholic fatty liver disease with Yindan Pinggan capsuleSemantic proximity Read

PFOS aggravates atherosclerosis via <i>Bacteroides caecimuris</i> expansion-driven bile acid remodeling and subsequent intestinal FXR–TLR3 signaling cascadeSemantic proximity Read